Beta-Lactams Dosing in Critically Ill Patients with Gram-Negative Bacterial Infections: A PK/PD Approach

Kelly L. Maguigan, Mohammad H. Al-Shaer, Charles A. Peloquin

Open source

DOI
10.3390/antibiotics10101154
Published
2021-09-24
Container
Antibiotics
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/antibiotics10101154,
  title = {Beta-Lactams Dosing in Critically Ill Patients with Gram-Negative Bacterial Infections: A PK/PD Approach},
  author = {Kelly L. Maguigan and Mohammad H. Al-Shaer and Charles A. Peloquin},
  year = {2021},
  journal = {Antibiotics},
  doi = {10.3390/antibiotics10101154},
  url = {https://doi.org/10.3390/antibiotics10101154}
}

RIS

TY  - JOUR
TI  - Beta-Lactams Dosing in Critically Ill Patients with Gram-Negative Bacterial Infections: A PK/PD Approach
AU  - Kelly L. Maguigan
AU  - Mohammad H. Al-Shaer
AU  - Charles A. Peloquin
PY  - 2021
JO  - Antibiotics
DO  - 10.3390/antibiotics10101154
UR  - https://doi.org/10.3390/antibiotics10101154
ER  - 

APA

Maguigan, K. L., Al-Shaer, M. H., & Peloquin, C. A. (2021). Beta-Lactams Dosing in Critically Ill Patients with Gram-Negative Bacterial Infections: A PK/PD Approach. Antibiotics. https://doi.org/10.3390/antibiotics10101154

Source records